Global Fluoroscopy and Mobile C-Arms Market to Reach US$1.3 Billion by 2015, According to New Report by Global Industry Analysts, Inc. GIA announces the release of a comprehensive global report on Fluoroscopy and Mobile C-Arms market. Even though growth variables remain temporarily challenged, a quick resurgence is forecasted in the post recession period with recovery in equipment utilization rates, rebound of replacement demand and favorable healthcare reforms that push patient throughput volumes. The world Fluoroscopy and Mobile C-Arms market is forecast to recover poise in the short-to-medium term period to reach US$1.3 billion by the year 2015.
San Jose, CA (Vocus/PRWEB) January 06, 2011
Fluoroscopy has long been considered as a risky imaging technique due to the over exposure of patients to X-rays. However, recent advancements in imaging technology and continued R&D have reduced the level of risks involved with the modality. Efforts are on to minimize the amount of patient's radiation exposure by employing sophisticated techniques. Such developments are likely to transform Fluoroscopy and Mobile C-Arms into a safer and better imaging technique in future, thereby promising to offer future growth opportunities in the market.
Pressure from the recession, which severely impacted most industrial sectors, has forced growth to slow down to a sluggish pace in the healthcare industry, which was once widely opined to be recession resilient. Although in vitro diagnostics, lives up to the recession-proof maxim, medical imaging equipment is nevertheless vulnerable to changes in reimbursement trends and economic cycles. With the financial crisis led economic recession resulting in tight liquidity, lack of credit availability, capital shortages, high borrowing rates, hospitals and healthcare facilities reduced capital expenditures on new equipments. In the United States, for instance, reductions in federal funding coupled with declines in philanthropic donations, have put hospitals under severe financial pressures thus blocking investments in medical equipments. Expensive imaging equipments, although still offer a sturdy value proposition from a technology standpoint, have temporarily lost their popularity due to a host of macro economic reasons, such as, decline in reimbursements of medical imaging, cutbacks in healthcare expenditure, budgetary constrains and postponement of equipment replacement decisions.
In contrast, demand for refurbished equipment rose during the recession period highlighting the extent of budget rationalization, and the trend towards stretching the lifespan of equipments. Although the above factors have slowed down the growth momentum to an average rate of 1.5% during the period 2007 through 2010, few other factors have helped the market ride over the recession without recording hurting erosions in market value. For instance, steady rise in equipment utilization rates as a result of demographic pressures has prevented deep capital budgets cuts, as hospitals cannot afford to postpone for long the resolution of issues related to workflow, scheduling, throughput, and equipment utilization. Another factor that has helped prevent major scaling back of investments in fluoroscopic imaging, is the fact that C-arm fluoroscopes are indispensable tools for intraoperative 2D imaging as they aid in accurate anatomic localization of implant placement thus explaining its widespread use in almost every medical discipline. Global demand for Full-Size C-Arms is expected to grow at a CAGR of 3.65% during 2007 through 2015. Also, digital fluoroscopy has and will continue to remain a central imaging modality in both inpatient and outpatient care. The post recession period will witness the intersection of two vectors that will aid in future growth – need for additional capacity and obsolescence. While obsolescence triggers the need for replacements, rising need for increased patient throughput exerts pressure on existing capacity thus providing a business case for new equipment purchases in a non-replacement scenario.
Market for Fluoroscopy and Mobile C-Arms will continue to be dominated by developed nations, with the US, Japan, and Europe together accounting for a lion's share of the global market, as stated by the new market research report. While budgetary crackdowns and unfavorable healthcare regulations sharpen the blow on developed markets like North America and Europe, developing markets in Asia-Pacific in contrast have had a relatively cushioned fall insulated by factors such as, rising awareness of the importance of quality healthcare, governmental support, greater emphasis on developing healthcare infrastructure and ability of the patient population to increasingly afford quality health services. Revenues for Mobile C-Arms in Asia-Pacific are expected to surge at a CAGR of 5.36% during the analysis period.
Major players in the marketplace include GE Healthcare, F&M Control, SL, Hologic, Inc., Imaging3, Inc., Philips Healthcare, Shimadzu Medical Systems, Siemens Medical Solutions, Toshiba Medical Systems Corp., Xograph Imaging Systems, Ziehm Imaging GmbH, among others.
The research report titled “Fluoroscopy and Mobile C-Arms: A Global Strategic Business Report” announced by Global Industry Analysts, Inc., provides a comprehensive review of market trends, issues, drivers, company profiles, mergers, acquisitions and other strategic industry activities. The report provides market estimates and projections (in Units and US$ Thousands) for major geographic markets including the United States, Canada, Japan, Europe (France, Germany, Italy, UK, Rest of Europe), Asia-Pacific and Rest of World. Product segments analyzed include Fluoroscopy, Mobile C-Arms (Full-Size C-Arms, Mini C-Arms).
For more details about this comprehensive market research report, please visit –
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 800 people worldwide and publishes more than 1200 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.
Global Fluoroscopy and Mobile C-Arms Market to Reach US$1.3 Billion by 2015, According to New Report by Global Industry Analysts, Inc. GIA announces the release of a comprehensive global report on Fluoroscopy and Mobile C-Arms market. Even though growth variables remain temporarily challenged, a quick resurgence is forecasted in the post recession period with recovery in equipment utilization rates, rebound of replacement demand and favorable healthcare reforms that push patient throughput volumes. The world Fluoroscopy and Mobile C-Arms market is forecast to recover poise in the short-to-medium term period to reach US$1.3 billion by the year 2015.
San Jose, CA (Vocus/PRWEB) January 06, 2011
Fluoroscopy has long been considered as a risky imaging technique due to the over exposure of patients to X-rays. However, recent advancements in imaging technology and continued R&D have reduced the level of risks involved with the modality. Efforts are on to minimize the amount of patient's radiation exposure by employing sophisticated techniques. Such developments are likely to transform Fluoroscopy and Mobile C-Arms into a safer and better imaging technique in future, thereby promising to offer future growth opportunities in the market.
Pressure from the recession, which severely impacted most industrial sectors, has forced growth to slow down to a sluggish pace in the healthcare industry, which was once widely opined to be recession resilient. Although in vitro diagnostics, lives up to the recession-proof maxim, medical imaging equipment is nevertheless vulnerable to changes in reimbursement trends and economic cycles. With the financial crisis led economic recession resulting in tight liquidity, lack of credit availability, capital shortages, high borrowing rates, hospitals and healthcare facilities reduced capital expenditures on new equipments. In the United States, for instance, reductions in federal funding coupled with declines in philanthropic donations, have put hospitals under severe financial pressures thus blocking investments in medical equipments. Expensive imaging equipments, although still offer a sturdy value proposition from a technology standpoint, have temporarily lost their popularity due to a host of macro economic reasons, such as, decline in reimbursements of medical imaging, cutbacks in healthcare expenditure, budgetary constrains and postponement of equipment replacement decisions.
In contrast, demand for refurbished equipment rose during the recession period highlighting the extent of budget rationalization, and the trend towards stretching the lifespan of equipments. Although the above factors have slowed down the growth momentum to an average rate of 1.5% during the period 2007 through 2010, few other factors have helped the market ride over the recession without recording hurting erosions in market value. For instance, steady rise in equipment utilization rates as a result of demographic pressures has prevented deep capital budgets cuts, as hospitals cannot afford to postpone for long the resolution of issues related to workflow, scheduling, throughput, and equipment utilization. Another factor that has helped prevent major scaling back of investments in fluoroscopic imaging, is the fact that C-arm fluoroscopes are indispensable tools for intraoperative 2D imaging as they aid in accurate anatomic localization of implant placement thus explaining its widespread use in almost every medical discipline. Global demand for Full-Size C-Arms is expected to grow at a CAGR of 3.65% during 2007 through 2015. Also, digital fluoroscopy has and will continue to remain a central imaging modality in both inpatient and outpatient care. The post recession period will witness the intersection of two vectors that will aid in future growth – need for additional capacity and obsolescence. While obsolescence triggers the need for replacements, rising need for increased patient throughput exerts pressure on existing capacity thus providing a business case for new equipment purchases in a non-replacement scenario.
Market for Fluoroscopy and Mobile C-Arms will continue to be dominated by developed nations, with the US, Japan, and Europe together accounting for a lion's share of the global market, as stated by the new market research report. While budgetary crackdowns and unfavorable healthcare regulations sharpen the blow on developed markets like North America and Europe, developing markets in Asia-Pacific in contrast have had a relatively cushioned fall insulated by factors such as, rising awareness of the importance of quality healthcare, governmental support, greater emphasis on developing healthcare infrastructure and ability of the patient population to increasingly afford quality health services. Revenues for Mobile C-Arms in Asia-Pacific are expected to surge at a CAGR of 5.36% during the analysis period.
Major players in the marketplace include GE Healthcare, F&M Control, SL, Hologic, Inc., Imaging3, Inc., Philips Healthcare, Shimadzu Medical Systems, Siemens Medical Solutions, Toshiba Medical Systems Corp., Xograph Imaging Systems, Ziehm Imaging GmbH, among others.
The research report titled “Fluoroscopy and Mobile C-Arms: A Global Strategic Business Report” announced by Global Industry Analysts, Inc., provides a comprehensive review of market trends, issues, drivers, company profiles, mergers, acquisitions and other strategic industry activities. The report provides market estimates and projections (in Units and US$ Thousands) for major geographic markets including the United States, Canada, Japan, Europe (France, Germany, Italy, UK, Rest of Europe), Asia-Pacific and Rest of World. Product segments analyzed include Fluoroscopy, Mobile C-Arms (Full-Size C-Arms, Mini C-Arms).
For more details about this comprehensive market research report, please visit –
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 800 people worldwide and publishes more than 1200 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.
News 
Market Data 
Discover 
